Allergy relief-D Cetirizine Hydrochloride and Pseudoephedrine 5 mg; 120 mg Tablet, Film Coated, Extended Release — NDC 70677-1020-02 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Allergy relief-D Cetirizine Hydrochloride and Pseudoephedrine 5 mg; 120 mg Tablet, Film Coated, Extended Release — NDC 70677-1020-2 (Billing 70677-1020-02)

by STRATEGIC SOURCING SERVICES LLC · 2 BLISTER PACK in 1 CARTON / 6 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK

This is a package of Allergy relief-D Cetirizine Hydrochloride and Pseudoephedrine 5 mg; 120 mg Tablet, Film Coated, Extended Release from STRATEGIC SOURCING SERVICES LLC, marketed since Aug 2023 and currently FDA-listed; retail pharmacies pay about $0.5625 per unit (NADAC).

NDC 70677-1020-02
🏷️ FDA NDC (as labeled) 70677-1020-2 billing pads the package segment with a zero
This package
Contains6 tablet, film coated, extended release in 1 blister pack Cost per ea$0.5625 NADAC Per package$6.75 / 12 tablets Pack sizes2 compare ↓
Also priced by: Medicaid pays $0.9033/unit — full pricing hub ↓
OTC Generic On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 70677-1020-2
Product NDC 70677-1020
11-digit billing NDC 70677102002
NCPDP billing unit EA — each (per item)
RxCUI 1014571
UNII 64O047KTOA, 6V9V2RYJ8N
Application # ANDA090922
SPL Set ID 97997887-9cba-48f8-abcd-fdb86829459c
Established class (EPC) Histamine-1 Receptor Antagonist; alpha-Adrenergic Agonist
Mechanism of action Adrenergic alpha-Agonists; Histamine H1 Receptor Antagonists
DEA schedule Non-controlled
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2023-08-11
Route ORAL
Dosage form TABLET, FILM COATED, EXTENDED RELEASE
Substance CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 43993002277420
GCN Seq No 048415
GCN 13866
HICL code 022864
Ingredient (HICL) Cetirizine Hcl/Pseudoephedrine
HIC1 code Z
Therapeutic class — broad (HIC1) Body As A Whole
HIC2 code Z2
Therapeutic class — intermediate (HIC2) Antihistamines, Antiserotonins, Immunosuppressants
HIC3 code Z2O
Therapeutic class — specific (HIC3) 2Nd Gen Antihistamine And Decongestant Combination
AHFS code 04:08.00.00
AHFS class Second Generation Antihistamines
FDB label name FT ALL DY ALLERGY-D 5-120MG TB
FDB brand name All Day Allergy-D
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 048415
  • GCN: 13866
  • GPI-14 (Medi-Span): 43993002277420
  • HICL (First Databank): 022864
  • AHFS class code: 04:08.00.00
  • RxCUI (RxNorm): 1014571
Why two NDCs? The FDA registers this code as 70677-1020-2 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 70677-1020-02. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Histamine-1 Receptor Antagonist class.

Pharmacologic class Histamine-1 Receptor Antagonist
Drug family (ATC) Piperazine derivatives, Other antiallergics
How it works Histamine H1 Receptor Antagonists
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name FT ALL DY ALLERGY-D 5-120MG TB Ingredient Cetirizine Hcl/Pseudoephedrine
📖 What it is MedlinePlus · NLM

Cetirizine injection is used to treat acute urticaria (sudden appearance of hives). Cetirizine is in a class of medications called antihistamines. It works by blocking the action of histamine, a substance in the body that causes allergic symptoms.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • Great question. It's a two-in-one product. Cetirizine is an antihistamine that targets allergy symptoms like runny nose, sneezing, and itchy, watery eyes. Pseudoephedrine is a deco...
  • What exactly does this medication do — why does it have two ingredients?
  • No — please don't. These are extended-release tablets, which means they're specially designed to release medication slowly over 12 hours. Breaking or chewing the tablet can dump to...
  • Can I break the tablet in half if it's hard to swallow?
📖 Read our full Cetirizine / Pseudoephedrine guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.563 $6.75 / 12 tablets
Medicaid paysCMS SDUD · 12 mo $0.9033 $10.84 / 12 tablets
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per ea) — tap or hover for the price & month
Dec 2025 Mar 2026 Jun 2026 Sep 2026 $0.596 $0.563
▼ Down 2% over the last 10 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Per unit Per pack Marketing startMarketing endStatus
70677-1020-01 70677-1020-1 Main listing 4 BLISTER PACK in 1 CARTON / 6 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK $0.5625 / ea $13.50 2023-08-11 — Active
70677-1020-02 You're viewing this 2 BLISTER PACK in 1 CARTON / 6 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK $0.5625 / ea $6.75 2024-10-04 — Active

This pack effectively ties for the lowest per-ea cost of the 2 priced pack sizes ($0.5625 NADAC).

This pack accounts for about 15% of this product's recent Medicaid fills; most go to a different pack size. See all packs ↓

Pack size FAQ

What quantity is in this package?
This package is listed by the FDA — 2 blister pack in 1 carton / 6 tablet, film coated, extended release in 1 blister pack.
What NDC number is used to bill for this package of Allergy relief-D Cetirizine Hydrochloride and Pseudoephedrine 5 mg; 120 mg Tablet, Film Coated, Extended Release?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
All Day Allergy D 5 mg/1; 120 mg 00113-2147-62 L. 1 tablet $0.563 — Availability likely —
Rugby Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride 5 mg/1; 120 mg 00536-1279-12 Rugby 1 tablet $0.563 — Availability likely —
Cetirizine hydrochloride and Pseudoephedrine hydrochloride 5 mg/1; 120 mg 45802-0147-53 Padagis 1 tablet $0.563 — Availability likely —
good neighbor pharmacy all day allergy d 5 mg/1; 120 mg 46122-0626-62 Amerisource 1 tablet $0.563 — Availability likely —
Leader Allergy Relief D 5 mg/1; 120 mg 70000-0042-01 Cardinal 1 tablet $0.563 — Availability likely —
Allergy relief-D 5 mg/1; 120 mgthis 70677-1020-02 STRATEGIC 6 tablets $0.563 — Availability likely —
Foster And Thrive All Day Allergy D 5 mg/1; 120 mg 70677-1311-01 Strategic 1 tablet $0.563 — Availability likely —
good sense all day allergy d 5 mg/1; 120 mg 00113-0147-53 L. 1 tablet — — Discontinued —
Wal-Zyr D 5 mg/1; 120 mg 00363-0989-12 Walgreen 6 tablets — — FDA listed —
allergy relief D12 5 mg/1; 120 mg 00363-4923-53 Walgreen 1 tablet — — FDA listed —
allergy relief-D 5 mg/1; 120 mg 11822-3009-00 Rite 1 tablet — — FDA listed —
Allergy relief-D 5 mg/1; 120 mg 11822-9994-01 RITE 6 tablets — — FDA listed —
signature care allergy relief d 5 mg/1; 120 mg 21130-0644-62 Safeway 1 tablet — — FDA listed —
all day allergy d 5 mg/1; 120 mg 30142-0450-62 Kroger 1 tablet — — FDA listed —
Allergy and Sinus Relief 5 mg/1; 120 mg 30142-0633-62 Kroger 1 tablet — — FDA listed —
topcare all day allergy d 5 mg/1; 120 mg 36800-0744-62 Topco 1 tablet — — FDA listed —
allergy relief d 5 mg/1; 120 mg 37808-0651-53 H 1 tablet — — FDA listed —
12 hour allergy d 5 mg/1; 120 mg 41250-0728-53 Meijer 1 tablet — — FDA listed —
Zyrtec-D 5 mg/1; 120 mg 50580-0719-12 Kenvue 6 tablets — — FDA listed —
ZYRTEC-D Allergy Plus Congestion 5 mg/1; 120 mg 50580-0728-12 Kenvue 6 tablets — — FDA listed —
Allergy Relief D12 5 mg/1; 120 mg 51316-0607-53 CVS 1 tablet — — FDA listed —
Allergy relief-D 5 mg/1; 120 mg 51660-0940-12 Ohm 6 tablets — — FDA listed —
allergy relief d 5 mg/1; 120 mg 56062-0147-53 Publix 1 tablet — — FDA listed —
Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride 5 mg/1; 120 mg 58602-0703-09 Aurohealth 2 tablets — — FDA listed —
Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride 5 mg/1; 120 mg 62756-0915-62 Sun 6 tablets — — FDA listed —
kirkland signature aller tec d 5 mg/1; 120 mg 63981-0147-62 Costco 1 tablet — — FDA listed —
Allergy relief-D 5 mg/1; 120 mg 68016-0531-24 CHAIN 24 tablets — — FDA listed —
allergy relief d 5 mg/1; 120 mg 69842-0415-53 CVS 1 tablet — — FDA listed —
Allergy Relief-D 5 mg/1; 120 mg 69842-0994-12 CVS 6 tablets — — FDA listed —
equate allergy relief d nasal decongestant 5 mg/1; 120 mg 79903-0126-14 WALMART 1 tablet — — FDA listed —
Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride 5 mg/1; 120 mg 29300-0313-22 Unichem 6 tablets — — FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2023
On the market since
Aug 2023
📍
2026
Currently FDA-listed
3 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color white
ShapeRound
Imprint915
Size9 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 5138Q19F1X
    Ammonia is a colorless gas made from nitrogen and hydrogen. It's used in medicines as a pH buffer to maintain the correct acidity level and help keep the product stable.
  • UNII 8PJ61P6TS3
    Butyl alcohol is a clear liquid organic solvent derived from petroleum or natural sources. In medicines, it helps dissolve active ingredients and serves as a solvent in liquid formulations and some topical products.
  • UNII XM0M87F357
    A dark iron oxide compound that gives medicines their black or dark color. It's used as a colorant in tablets and capsules to help identify the product and make it visually distinctive.
  • UNII ZYD53NBL45
    Hydroxyethyl cellulose is a plant-based thickening agent derived from cellulose. It helps control the texture and consistency of liquid or semi-solid medicines, and may also help keep ingredients evenly mixed throughout the product.
  • UNII RFW2ET671P
    Hydroxypropyl cellulose is a plant-derived thickening agent made from cellulose. It acts as a binder to hold tablet ingredients together and as a film-former to coat tablets or control how fast the medicine releases.
  • UNII 3NXW29V3WO
    Hypromellose is a plant-based thickener made from cellulose. It's used in medicines as a binder to hold ingredients together, a coating for tablets, and a thickener for liquids.
  • UNII ND2M416302
    Isopropyl alcohol is a clear liquid solvent derived from petroleum. In medicines, it dissolves active ingredients and other components, helps the product flow smoothly, and aids in sterilization during manufacturing.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII OP1R32D61U
    Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
  • UNII 6DC9Q167V3
    Propylene glycol is a clear liquid derived from petroleum or vegetable sources. It acts as a solvent, humectant, and preservative in medicines, helping dissolve active ingredients and maintain product stability.
  • UNII 46N107B71O
    Shellac is a natural resin secreted by the lac beetle. It's used as a coating on tablets and capsules to control how quickly the medicine dissolves and to improve appearance and stability.
  • UNII 4ELV7Z65AP
    Stearic acid is a fatty acid derived from plant or animal sources. It acts as a binder and lubricant in tablets and capsules, helping them hold together and flow smoothly during manufacturing.
  • UNII 15FIX9V2JP
    Titanium dioxide is a bright white mineral powder commonly used as a colorant and opacifying agent. It makes pills and tablets white or lighter in color and helps make coatings non-transparent.

13 inactive ingredients listed in the exact product block matched to this NDC.

The official label also stateshydroxyethyl cellulose, hydroxypropyl cellulose, hypromellose, magnesium stearate, microcrystalline cellulose, stearic acid, titanium dioxide

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerSTRATEGIC SOURCING SERVICES LLC
Application holderSUN PHARMACEUTICAL INDUSTRIES LTD
FDA applicationANDA090922 (ANDA)
Labeler code70677
First marketedAug 2023
Product typeHuman Otc Drug
Portfolio316 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 45 words ▾

Uses temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose sneezing itchy, watery eyes itching of nose or throat nasal congestion reduces swelling of nasal passages temporarily relieves sinus congestion and pressure temporarily restores freer breathing through the nose

⏱️ Dosage and Administration 59 words ▾

Directions do not break or chew tablet; swallow tablet whole adults and children 12 years and over take 1 tablet every 12 hours; do not take more than 2 tablets in 24 hours. adults 65 years and over ask a doctor children under 12 years of age ask a doctor consumers with liver or kidney disease ask a doctor

⚠️ Warnings ~1 min read ▾

Warnings Do not use if you have ever had an allergic reaction to this product or any of its ingredients or to an antihistamine containing hydroxyzine. if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product. Ask a doctor before use if you have heart disease thyroid disease diabetes glaucoma high blood pressure trouble urinating due to an enlarged prostate gland liver or kidney disease.

Your doctor should determine if you need a different dose. Ask a doctor or pharmacist before use if you are taking tranquilizers or sedatives. When using this product do not use more than directed drowsiness may occur avoid alcoholic drinks alcohol, sedatives, and tranquilizers may increase drowsiness be careful when driving a motor vehicle or operating machinery Stop use and ask a doctor if an allergic reaction to this product occurs.

Seek medical help right away. you get nervous, dizzy, or sleepless symptoms do not improve within 7 days or are accompanied by fever If pregnant or breast-feeding if breast-feeding: not recommended if pregnant: ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away at 1-800-222-1222.

📦 Storage and Handling 33 words ▾

Other information store between 20° to 25°C (68° to 77°F) do not use if carton is opened or if the blister unit is broken see side panel for batch number and expiration date

🧪 Active Ingredient 20 words ▾

Active ingredients (in each extended-release tablet) Purposes Cetirizine HCl, USP 5 mg Antihistamine Pseudoephedrine HCl, USP 120 mg Nasal decongestant

🧪 Inactive Ingredients 31 words ▾

Inactive ingredients hydroxyethyl cellulose, hydroxypropyl cellulose, hypromellose, magnesium stearate, microcrystalline cellulose, stearic acid, titanium dioxide Imprinting Ink Contents ammonium hydroxide, iron oxide black, isopropyl alcohol, N-butyl alcohol, propylene glycol, shellac glaze

🎯 Purpose 20 words ▾

Active ingredients (in each extended-release tablet) Purposes Cetirizine HCl, USP 5 mg Antihistamine Pseudoephedrine HCl, USP 120 mg Nasal decongestant

📄 Do Not Use 77 words ▾

Do not use if you have ever had an allergic reaction to this product or any of its ingredients or to an antihistamine containing hydroxyzine. if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.

📄 Ask a Doctor Before Use If 39 words ▾

Ask a doctor before use if you have heart disease thyroid disease diabetes glaucoma high blood pressure trouble urinating due to an enlarged prostate gland liver or kidney disease. Your doctor should determine if you need a different dose.

📄 Ask a Doctor or Pharmacist Before Use If 14 words ▾

Ask a doctor or pharmacist before use if you are taking tranquilizers or sedatives.

📄 When Using This Product 33 words ▾

When using this product do not use more than directed drowsiness may occur avoid alcoholic drinks alcohol, sedatives, and tranquilizers may increase drowsiness be careful when driving a motor vehicle or operating machinery

📄 Stop Use and Ask a Doctor If 37 words ▾

Stop use and ask a doctor if an allergic reaction to this product occurs. Seek medical help right away. you get nervous, dizzy, or sleepless symptoms do not improve within 7 days or are accompanied by fever

🤰 If Pregnant or Breast-Feeding 16 words ▾

If pregnant or breast-feeding if breast-feeding: not recommended if pregnant: ask a health professional before use.

📄 Keep Out of Reach of Children 23 words ▾

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away at 1-800-222-1222.

📄 Questions or Comments 12 words ▾

Questions? Call 833-358-6431 Monday to Friday 9:00 am to 7:00 pm EST

📄 Package Label / Principal Display Panel 87 words ▾

PRINCIPAL DISPLAY PANEL - 24 Tablet Blister Card Carton NDC 70677-1020-1 COMPARE TO ZYRTEC-D ® 12 HR ACTIVE INGREDIENTS* Foster & Thrive™ ORIGINAL PRESCRIPTION STRENGTH All Day Allergy-D Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride Extended-release Tablets, USP 5 mg/120 mg ANTIHISTAMINE/NASAL DECONGESTANT Indoor & Outdoor Allergies | Allergy & Sinus 12 hour relief of: Sneezing Itchy, Watery Eyes Sinus Pressure Runny Nose Itchy Throat or Nose Nasal Congestion ACTUAL SIZE 24 TABLETS (4 blister cards of 6 tablets each) PRINCIPAL DISPLAY PANEL - 24 Tablet Blister Card Carton

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q2 2025 – Q1 2026 · 4 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
54
Units reimbursed last 4 qtrs
1.2K
Gross reimbursed last 4 qtrs
$1.1K
Avg / prescription
$20.41
Avg / unit
$0.9033
Latest quarter Q1 2026
41Rx
Medicaid pays / ea
$0.9033
gross reimbursed
vs
NADAC / ea
$0.5625
acquisition cost
=
Spread
+$0.3408
+61% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
100% MCO
Fee-for-service · 0 Rx Managed care · 54 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: no data reported WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: no data reported MN Wisconsin: no data reported WI Michigan: no data reported MI New York: no data reported NY Vermont: no data reported VT New Hampshire: no data reported NH Oregon: no data reported OR Nevada: no data reported NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: no data reported IL Indiana: no data reported IN Ohio: 274 units · 2.3 per 100k residents OH Pennsylvania: no data reported PA New Jersey: 384 units · 4.1 per 100k residents NJ Massachusetts: no data reported MA California: no data reported CA Utah: no data reported UT Colorado: no data reported CO Nebraska: no data reported NE Missouri: no data reported MO Kentucky: no data reported KY West Virginia: no data reported WV Virginia: no data reported VA Maryland: no data reported MD Connecticut: no data reported CT Rhode Island: no data reported RI Arizona: no data reported AZ New Mexico: no data reported NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: no data reported SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: 562 units · 19.1 per 100k residents MS Alabama: no data reported AL Georgia: no data reported GA D.C.: no data reported DC Hawaii: no data reported HI Texas: no data reported TX Florida: no data reported FL
Units reimbursed · per 100k residents
2.319.1
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 Mississippi 19.1 /100k
2 New Jersey 4.1 /100k
3 Ohio 2.3 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

Medicaid utilization by pack size

Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.
6 tablets70677-1020-01 295 Rx · $7,540
Drug total (last 4 qtrs): 349 Rx · 9,268 units · $8,642 gross reimbursed
Tap a pack size to open its page. Source: CMS State Drug Utilization Data, last 4 quarters.

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride — the ingredient across all brands.

Top reported reactions

Fatigue411
Pain404
Rash356
Abdominal Discomfort336
Alopecia329
Rheumatoid Arthritis324
Pemphigus322

Age at onset

Neonate9
Infant4
Child49
Adolescent39
Adult640
Elderly239

Reporter sex

2,995 reports
Male · 23%
Female · 77%

Serious outcomes

Hospitalization504
Disabling393
Life-threatening339
Death307
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 300 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.